Fumiko Miyanaga

1.7k total citations · 1 hit paper
10 papers, 1.3k citations indexed

About

Fumiko Miyanaga is a scholar working on Endocrine and Autonomic Systems, Epidemiology and Nutrition and Dietetics. According to data from OpenAlex, Fumiko Miyanaga has authored 10 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrine and Autonomic Systems, 5 papers in Epidemiology and 5 papers in Nutrition and Dietetics. Recurrent topics in Fumiko Miyanaga's work include Regulation of Appetite and Obesity (8 papers), Biochemical Analysis and Sensing Techniques (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Fumiko Miyanaga is often cited by papers focused on Regulation of Appetite and Obesity (8 papers), Biochemical Analysis and Sensing Techniques (5 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Fumiko Miyanaga collaborates with scholars based in Japan and United States. Fumiko Miyanaga's co-authors include Kazuwa Nakao, Ken Ebihara, Kiminori Hosoda, Yoshihiro Ogawa, Tatsuya Hayashi, Mitsuyo Shintani, Megumi Aizawa‐Abe, Gen Inoue, Masayasu Kojima and Kazuhiko Takaya and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes and Diabetologia.

In The Last Decade

Fumiko Miyanaga

10 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway

2001 690 citations Mitsuyo Shintani, Yoshihiro Ogawa et al. Diabetes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fumiko Miyanaga Japan	9	880	643	552	297	259	10	1.3k
Mitsuyo Shintani Japan	7	801 0.9×	568 0.9×	527 1.0×	213 0.7×	211 0.8×	10	1.1k
Laura Oksanen Finland	16	767 0.9×	569 0.9×	444 0.8×	344 1.2×	261 1.0×	19	1.4k
Anne E. Evans United States	8	806 0.9×	618 1.0×	429 0.8×	333 1.1×	143 0.6×	11	1.4k
Charlotta Dornonville de la Cour Sweden	12	848 1.0×	542 0.8×	612 1.1×	120 0.4×	116 0.4×	19	1.1k
Nickki Ottaway United States	15	543 0.6×	454 0.7×	243 0.4×	237 0.8×	220 0.8×	17	1.0k
Tohru Yasuda Japan	12	535 0.6×	527 0.8×	183 0.3×	433 1.5×	188 0.7×	14	1.1k
Tomomi Shiiya Japan	13	1.6k 1.8×	984 1.5×	1.1k 2.0×	285 1.0×	84 0.3×	15	2.0k
Jill A. Willency United States	7	923 1.0×	694 1.1×	640 1.2×	99 0.3×	198 0.8×	8	1.3k
Kajsa Lindell Sweden	10	617 0.7×	474 0.7×	247 0.4×	432 1.5×	112 0.4×	11	1.2k
Kristy M. Heppner United States	21	672 0.8×	738 1.1×	338 0.6×	220 0.7×	424 1.6×	27	1.7k

Countries citing papers authored by Fumiko Miyanaga

Since Specialization

Citations

This map shows the geographic impact of Fumiko Miyanaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumiko Miyanaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumiko Miyanaga more than expected).

Fields of papers citing papers by Fumiko Miyanaga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumiko Miyanaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumiko Miyanaga. The network helps show where Fumiko Miyanaga may publish in the future.

Co-authorship network of co-authors of Fumiko Miyanaga

This figure shows the co-authorship network connecting the top 25 collaborators of Fumiko Miyanaga. A scholar is included among the top collaborators of Fumiko Miyanaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumiko Miyanaga. Fumiko Miyanaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Fujikura, Junji, Ken Ebihara, Fumiko Miyanaga, et al.. (2011). Therapeutic Impact of Leptin on Diabetes, Diabetic Complications, and Longevity in Insulin-Deficient Diabetic Mice. Diabetes. 60(9). 2265–2273. 49 indexed citations

Kusakabe, Toru, Ken Ebihara, M. Hirata, et al.. (2009). Beneficial effects of leptin on glycaemic and lipid control in a mouse model of type 2 diabetes with increased adiposity induced by streptozotocin and a high-fat diet. Diabetologia. 52(4). 675–683. 83 indexed citations

Ebihara, Ken, Toru Kusakabe, Masakazu Hirata, et al.. (2006). Efficacy and Safety of Leptin-Replacement Therapy and Possible Mechanisms of Leptin Actions in Patients with Generalized Lipodystrophy. The Journal of Clinical Endocrinology & Metabolism. 92(2). 532–541. 176 indexed citations

Tanaka, Tomohiro, Hiroaki Masuzaki, Ken Ebihara, et al.. (2005). Transgenic expression of mutant peroxisome proliferator–activated receptor γ in liver precipitates fasting–induced steatosis but protects against high-fat diet–induced steatosis in mice. Metabolism. 54(11). 1490–1498. 18 indexed citations

Ebihara, Ken, Toru Kusakabe, Hiroaki Masuzaki, et al.. (2004). Gene and Phenotype Analysis of Congenital Generalized Lipodystrophy in Japanese: A Novel Homozygous Nonsense Mutation in Seipin Gene. The Journal of Clinical Endocrinology & Metabolism. 89(5). 2360–2364. 40 indexed citations

Miyanaga, Fumiko, Yoshihiro Ogawa, Ken Ebihara, et al.. (2003). Leptin as an adjunct of insulin therapy in insulin-deficient diabetes. Diabetologia. 46(10). 1329–1337. 43 indexed citations

Ogawa, Yoshihiro, Hiroaki Masuzaki, Ken Ebihara, et al.. (2002). Pathophysiogical role of leptin in lifestyle-related diseases. Journal of Diabetes and its Complications. 16(1). 119–122. 11 indexed citations

Shintani, Mitsuyo, Yoshihiro Ogawa, Ken Ebihara, et al.. (2001). Ghrelin, an Endogenous Growth Hormone Secretagogue, Is a Novel Orexigenic Peptide That Antagonizes Leptin Action Through the Activation of Hypothalamic Neuropeptide Y/Y1 Receptor Pathway. Diabetes. 50(2). 227–232. 690 indexed citations breakdown →

Hidaka, Shigekazu, Yoshihiro Ogawa, Ken Ebihara, et al.. (2001). [Pathology and significance of leptin resistance in obesity].. PubMed. 59(3). 472–80. 2 indexed citations

10.

Ebihara, Ken, Yoshihiro Ogawa, Hiroaki Masuzaki, et al.. (2001). Transgenic Overexpression of Leptin Rescues Insulin Resistance and Diabetes in a Mouse Model of Lipoatrophic Diabetes. Diabetes. 50(6). 1440–1448. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact